关注
Cristina Adela Iuga
Cristina Adela Iuga
Iuliu Hatieganu University of Medicine and Pharmacy - Faculty of Pharmacy; MEDFUTURE Research Center
在 umfcluj.ro 的电子邮件经过验证
标题
引用次数
引用次数
年份
From extraction to advanced analytical methods: The challenges of melanin analysis
IE Pralea, RC Moldovan, AM Petrache, M Ilieș, SC Hegheș, I Ielciu, ...
International journal of molecular sciences 20 (16), 3943, 2019
2002019
Soy isoflavones and breast cancer cell lines: molecular mechanisms and future perspectives
A Uifălean, S Schneider, C Ionescu, M Lalk, CA Iuga
Molecules 21 (1), 13, 2015
1092015
Antispasmodic effect of essential oils and their constituents: A review
SC Heghes, O Vostinaru, LM Rus, C Mogosan, CA Iuga, L Filip
Molecules 24 (9), 1675, 2019
852019
The impact of soy isoflavones on MCF-7 and MDA-MB-231 breast cancer cells using a global metabolomic approach
A Uifălean, S Schneider, P Gierok, C Ionescu, CA Iuga, M Lalk
International Journal of Molecular Sciences 17 (9), 1443, 2016
652016
Proteomic identification of potential prognostic biomarkers in resectable pancreatic ductal adenocarcinoma
C Iuga, A Seicean, C Iancu, R Buiga, PK Sappa, U Völker, E Hammer
Proteomics 14 (7-8), 945-955, 2014
522014
Profiling alterations in platelets induced by Amotosalen/UVA pathogen reduction and gamma irradiation-a LC-ESI-MS/MS-based proteomics approach
T Thiele, A Sablewski, C Iuga, T Bakchoul, A Bente, S Görg, U Völker, ...
Blood Transfusion 10 (Suppl 2), s63, 2012
422012
Early storage lesions in apheresis platelets are induced by the activation of the integrin αIIbβ3 and focal adhesion signaling pathways
T Thiele, C Iuga, S Janetzky, H Schwertz, MG Salazar, B Fürll, U Völker, ...
Journal of proteomics 76, 297-315, 2012
412012
Compatibility studies of indapamide/pharmaceutical excipients used in tablet preformulation
LM Rus, I Tomuta, C Iuga, C Maier, I Kacso, G Borodi, I Bratu, M Bojita
Farmacia 60 (1), 92-101, 2012
402012
The relevance of mass spectrometry analysis for personalized medicine through its successful application in cancer “Omics”
CA Ciocan-Cartita, A Jurj, M Buse, D Gulei, C Braicu, L Raduly, ...
International Journal of Molecular Sciences 20 (10), 2576, 2019
382019
Safety profile of nutraceuticals rich in coumarins: An update
SC Heghes, O Vostinaru, C Mogosan, D Miere, CA Iuga, L Filip
FRONTIERS in Pharmacology 13, 803338, 2022
332022
Essential oil-bearing plants from Balkan Peninsula: Promising sources for new drug candidates for the prevention and treatment of diabetes mellitus and dyslipidemia
SC Heghes, L Filip, O Vostinaru, C Mogosan, D Miere, CA Iuga, ...
Frontiers in Pharmacology 11, 989, 2020
312020
Valuable food molecules with potential benefits for human health
LC Salanță, A Uifălean, CA Iuga, M Tofană, J Cropotova, OL Pop, ...
The Health Benefits of Foods-Current Knowledge and Further Development, 1-45, 2020
312020
Compatibility studies between drugs and excipients in the preformulation phase of buccal mucoadhesive systems
E Dinte, E Bodoki, S Leucuta, CA Iuga
Farmacia 61 (4), 703-712, 2013
282013
Development of a validated RP-HPLC method for separation and determination of process-related impurities of omeprazole in bulk drugs
C Iuga, M Bojita, SE Leucuta
Farmacia 57 (5), 534-541, 2009
262009
The pharmaceutical applications of a biopolymer isolated from Trigonella foenum-graecum seeds: Focus on the freeze-dried matrix forming capacity
S Iurian, E Dinte, C Iuga, C Bogdan, I Spiridon, L Barbu-Tudoran, ...
Saudi pharmaceutical journal 25 (8), 1217-1225, 2017
242017
Impact of blood sample collection methods on blood protein profiling studies
M Ilies, CA Iuga, F Loghin, VM Dhople, T Thiele, U Völker, E Hammer
Clinica chimica acta 471, 128-134, 2017
242017
Serum interleukin (IL)-23 and IL-17 profile in inflammatory bowel disease (IBD) patients could differentiate between severe and non-severe disease
LA Lucaciu, M Ilieș, ȘC Vesa, R Seicean, S Din, CA Iuga, A Seicean
Journal of personalized medicine 11 (11), 1130, 2021
232021
Serum levels of soluble programmed death-ligand 1 (sPD-L1): A possible biomarker in predicting post-treatment outcomes in patients with early hepatocellular carcinoma
T Mocan, M Ilies, I Nenu, R Craciun, A Horhat, R Susa, I Minciuna, I Rusu, ...
International immunopharmacology 94, 107467, 2021
222021
Quantification of the PEGylated gold nanoparticles protein corona. Influence on nanoparticle size and surface chemistry
R Nicoară, M Ilieș, A Uifălean, CA Iuga, F Loghin
Applied Sciences 9 (22), 4789, 2019
202019
Dietary fiber and metabolism
R Suharoschi, OL Pop, RA Vlaic, CI Muresan, CC Muresan, A Cozma, ...
Dietary fiber: Properties, recovery, and applications, 59-77, 2019
202019
系统目前无法执行此操作，请稍后再试。
文章 1–20